Alvaro Del Real1, Leyre Riancho-Zarrabeitia2, Laura López-Delgado1, José A Riancho3. 1. Department of Internal Medicine, Hospital U.M. Valdecilla IDIVAL, University of Cantabria, 39008, Santander, Spain. 2. Service of Rheumatology, Hospital Sierrallana, Torrelavega, Spain. 3. Department of Internal Medicine, Hospital U.M. Valdecilla IDIVAL, University of Cantabria, 39008, Santander, Spain. rianchoj@unican.es.
Abstract
PURPOSE OF REVIEW: Epigenetic mechanisms modify gene activity in a stable manner without altering DNA sequence. They participate in the adaptation to the environment, as well as in the pathogenesis of common complex disorders. We provide an overview of the role of epigenetic mechanisms in bone biology and pathology. RECENT FINDINGS: Extensive evidence supports the involvement of epigenetic mechanisms (DNA methylation, post-translational modifications of histone tails, and non-coding RNAs) in the differentiation of bone cells and mechanotransduction. A variety of epigenetic abnormalities have been described in patients with osteoporosis, osteoarthritis, and skeletal cancers, but their actual pathogenetic roles are still unclear. A few drugs targeting epigenetic marks have been approved for neoplastic disorders, and many more are being actively investigated. Advances in the field of epigenetics underscore the complex interactions between genetic and environmental factors as determinants of osteoporosis and other common disorders. Likewise, they help to explain the mechanisms by which prenatal and post-natal external factors, from nutrition to psychological stress, impact our body and influence the risk of later disease.
PURPOSE OF REVIEW: Epigenetic mechanisms modify gene activity in a stable manner without altering DNA sequence. They participate in the adaptation to the environment, as well as in the pathogenesis of common complex disorders. We provide an overview of the role of epigenetic mechanisms in bone biology and pathology. RECENT FINDINGS: Extensive evidence supports the involvement of epigenetic mechanisms (DNA methylation, post-translational modifications of histone tails, and non-coding RNAs) in the differentiation of bone cells and mechanotransduction. A variety of epigenetic abnormalities have been described in patients with osteoporosis, osteoarthritis, and skeletal cancers, but their actual pathogenetic roles are still unclear. A few drugs targeting epigenetic marks have been approved for neoplastic disorders, and many more are being actively investigated. Advances in the field of epigenetics underscore the complex interactions between genetic and environmental factors as determinants of osteoporosis and other common disorders. Likewise, they help to explain the mechanisms by which prenatal and post-natal external factors, from nutrition to psychological stress, impact our body and influence the risk of later disease.
Entities:
Keywords:
Adaptation; DNA methylation; Epigenetics; Fractures; Histones; microRNA
Authors: Ola Landgren; Robert A Kyle; Ruth M Pfeiffer; Jerry A Katzmann; Neil E Caporaso; Richard B Hayes; Angela Dispenzieri; Shaji Kumar; Raynell J Clark; Dalsu Baris; Robert Hoover; S Vincent Rajkumar Journal: Blood Date: 2009-01-29 Impact factor: 22.113
Authors: Claudine Seeliger; Katrin Karpinski; Alexander T Haug; Helen Vester; Andreas Schmitt; Jan S Bauer; Martijn van Griensven Journal: J Bone Miner Res Date: 2014-08 Impact factor: 6.741
Authors: Elizabeth M Curtis; Robert Murray; Philip Titcombe; Eloïse Cook; Rebecca Clarke-Harris; Paula Costello; Emma Garratt; Joanna D Holbrook; Sheila Barton; Hazel Inskip; Keith M Godfrey; Christopher G Bell; Cyrus Cooper; Karen A Lillycrop; Nicholas C Harvey Journal: J Bone Miner Res Date: 2017-05-22 Impact factor: 6.741
Authors: Marietta Herrmann; Klaus Engelke; Regina Ebert; Sigrid Müller-Deubert; Maximilian Rudert; Fani Ziouti; Franziska Jundt; Dieter Felsenberg; Franz Jakob Journal: Biomolecules Date: 2020-03-10
Authors: Martina Rauner; Ines Foessl; Melissa M Formosa; Erika Kague; Vid Prijatelj; Nerea Alonso Lopez; Bodhisattwa Banerjee; Dylan Bergen; Björn Busse; Ângelo Calado; Eleni Douni; Yankel Gabet; Natalia García Giralt; Daniel Grinberg; Nika M Lovsin; Xavier Nogues Solan; Barbara Ostanek; Nathan J Pavlos; Fernando Rivadeneira; Ivan Soldatovic; Jeroen van de Peppel; Bram van der Eerden; Wim van Hul; Susanna Balcells; Janja Marc; Sjur Reppe; Kent Søe; David Karasik Journal: Front Endocrinol (Lausanne) Date: 2021-11-30 Impact factor: 5.555